|
1
|
Falany CN: Enzymology of human cytosolic
sulfotransferases. FASEB J. 11:206–216. 1997.PubMed/NCBI
|
|
2
|
Glatt H, Engelke CE, Pabel U, Teubner W,
Jones AL, Coughtrie MW, Andrae U, Falany CN and Meinl W:
Sulfotransferases: genetics and role in toxicology. Toxicol Lett.
112:341–348. 2000. View Article : Google Scholar
|
|
3
|
Richard K, Hume R, Kaptein E, Stanley EL,
Visser TJ and Coughtrie MW: Sulfation of thyroid hormone and
dopamine during human development: ontogeny of phenol
sulfotransferases and arylsulfatase in liver, lung, and brain. J
Clin Endocrinol Metab. 86:2734–2742. 2001.
|
|
4
|
Blanchard RL, Freimuth RR, Buck J,
Weinshilboum RM and Coughtrie MW: A proposed nomenclature system
for the cytosolic sulfotransferase (SULT) superfamily.
Pharmacogenetics. 14:199–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raftogianis RB, Wood TC, Otterness DM, Van
Loon JA and Weinshilboum RM: Phenol sulfotransferase
pharmacogenetics in human: association of common SULT1A1 alleles
with TS PST phenotype. Biochem Biophys Res Commun. 239:298–304.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nowell S, Ambrosone CB, Ozawa S, MacLeod
SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF and Lang NP:
Relationship of phenol sulfotransferase activity (SULT1A1) genotype
to sulfotransferase phenotype in platelet cytosol.
Pharmacogenetics. 10:789–797. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
National Cancer Institute: Annual Report
to the Nation Finds Declines in Cancer Incidence and Death Rates;
Special Feature Reveals Wide Variations in Lung Cancer Trends
across States. https://www.cancer.gov/newscenter/pressreleases/2008/reportnation2008release.
|
|
8
|
Dearnaley DP: Cancer of the prostate. BMJ.
308:780–784. 1994.Erratum in: BMJ 308: 975, 1994.
|
|
9
|
Bamber DE, Fryer AA, Strange RC, Elder JB,
Deakin M, Rajagopal R, Fawole A, Gilissen RA, Campbell FC and
Coughtrie MW: Phenol sulfotransferase SUL1A1*1 genotype
is associated with reduced risk of colorectal cancer.
Pharmacogenetics. 11:679–685. 2001.
|
|
10
|
Boccia S, Persiani R, La Torre G, Rausei
S, Arzani D, Gianfagna F, Romano-Spica V, D’Ugo D and Ricciardi G:
Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot
case-control study. Cancer Lett. 229:235–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nowell S, Ratnasinghe DL, Ambrosone CB,
Williams S, Teague-Ross T, Trimble L, Runnels G, Carrol A, Green B,
Stone A, Johnson D, Greene G, Kadlubar FF and Lang NP: Association
of SULT1A1 phenotype and genotype with prostate cancer risk in
African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev.
13:270–276. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF,
Lee TP, Shih MC, Chang JY and Chang JG: The relationship among the
polymorphisms of SULT1A1, 1A2 and different types of cancers in
Taiwanese. Int J Mol Med. 11:85–89. 2003.PubMed/NCBI
|
|
13
|
Seth P, Lunetta KL, Bell DW, Gray H,
Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE,
Haber DA and Polyak K: Phenol sulfotransferases: hormonal
regulation, polymorphism, and age of onset of breast cancer. Cancer
Res. 60:6859–6863. 2000.PubMed/NCBI
|
|
14
|
Silig Y, Pinarbası H, Güneş S, Ayan S,
Bagci H and Çetinkaya Ö: Polymorphisms of CYP1A1, GSTM1, GSTT1, and
prostate cancer risk in Turkish population. Cancer Invest.
24:41–45. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steiner M, Bastian M, Schulz WA, Pulte T,
Franke KH, Röhring A, Wolff JM, Seiter H and Schuff-Werner P:
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer:
lack of association. Arch Toxicol. 74:222–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng W, Xie D, Cerhan JR, Sellers TA, Wen
W and Folsom AR: Sulfotransferase 1A1 polymorphism, endogenous
estrogen exposure, well-done meat-intake, and breast cancer risk.
Cancer Epidemiol Biomarkers Prev. 10:89–94. 2001.PubMed/NCBI
|
|
17
|
Sambrook J, Fritsch E and Maniatis T:
Molecular Cloning A Laboratory Manual. 2nd edition. Cold Spring
Harbor Laboratory Press; Plainview: 1989
|
|
18
|
Wormhoudt LW, Commandeur JN and Vermeulen
NP: Genetic polymorphisms of human N-acetyltransferase, cytochrome
P450, glutathione-S-transferase, and epoxide hydrolase enzymes:
relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol.
29:59–124. 1999. View Article : Google Scholar
|
|
19
|
Coughtrie MW, Gilissen RA, Shek B, Strange
RC, Fryer AA, Jones PW and Bamber DE: Phenol sulphotransferase
SULT1A1 polymorphism: molecular diagnosis and allele frequencies in
Caucasian and African populations. Biochem J. 337:45–49. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arslan S, Siliğ Y and Pınarbaşı H: An
investigation of the relationship between SULT1A1
Arg213His polymorphism and lung cancer susceptibility in
a Turkish population. Cell Biochem Funct. 27:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim KA, Lee SY, Park PW, Ha JM and Park
JY: Genetic polymorphisms and linkage disequilibrium of
sulfotransferase SULT1A1 and SULT1A2 in a Korean population:
comparison of other ethnic groups. Eur J Clin Pharmacol.
61:743–747. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bardakci F, Arslan S, Bardakci S, Binatli
AO and Budak M: Sulfotransferase 1A1 (SULT1A1) polymorphism and
susceptibility to primary brain tumors. J Cancer Res Clin Oncol.
134:109–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Banoglu E: Current status of the cytosolic
sulfotransferases in the metabolic activation of promutagens and
procarcinogens. Curr Drug Metab. 1:1–30. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shirai T, Tamano S, Sano M, Masui T,
Hasegawa R and Ito N: Carcinogenicity of
2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in rats:
dose-response studies. Princess Takamatsu Symp. 23:232–239.
1995.
|
|
25
|
Chou HC, Lang NP and Kadlubar FF:
Metabolic activation of the N-hydroxy derivative of the carcinogen
4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis.
16:413–417. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ozawa S, Chou HC, Kadlubar FF, Nagata K,
Yamazoe Y and Kato R: Activation of
2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by
cDNA-expressed human and rat arylsulfotransferases. Jpn J Cancer
Res. 85:1220–1228. 1994.
|
